ZKG-28673-57141
4 vaccinations
3 coded responses
50 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 782 / TX
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
ZR5-16990-23963
Child or adolescent in my care · Female · 2022-06-26
T2S-27427-89575
Child or adolescent in my care · Female · 2022-06-26
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-17
- 2020-12-18
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-01-13
- 2021-01-16
-
2021-01-21
Survey response — day 14, dose 2MedDRA: Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: UTIMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-20
-
2021-03-26
Call successfulParticipant prefers to complete VAERS report online
- 2021-04-08
- 2021-07-08
-
2021-09-21
Dose 3 — Pfizer-BioNTech
- 2021-09-21
-
2021-09-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-25
-
2021-09-26
Survey response — days 1–6 daily, dose 3MedDRA: Swelling of eyelid — Feeling: Good · Fatigue or tirednessFree text: Swelling of left upper eye lidMedDRA releases: 2024-11 · check-in free text available
- 2021-09-27
- 2021-09-28
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-12-21
- 2022-03-22
- 2022-09-24
-
2022-09-28
Dose 4 — Pfizer-BioNTech
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-30
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-06
- 2022-10-13
- 2022-10-21
- 2022-10-28
- 2022-11-02
- 2022-11-09
-
2022-12-30
Survey response — 3 months, dose 4MedDRA: Cough, Respiratory tract congestion — Feeling: FairFree text: Congestion and coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-21 | Pfizer-BioNTech | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-08 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-21 | Successful 2021-03-26 |
Participant prefers to complete VAERS report online |
Free text
Release 2 — day 14, dose 2
Symptoms: UTI
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swelling of left upper eye lid
Release 12 — 3 months, dose 4
Symptoms: Congestion and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
| SRO | Swelling of eyelid | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release